There are 717 resources available
436P - Clinicopathological characteristics and outcomes of adolescent and young adult (AYA) melanoma: Results from an Asian perspective
Presenter: Wei Lin Goh
Session: e-Poster Display Session
437P - Long-term efficacy and toxicity outcome of adjuvant external beam radiotherapy for medullary thyroid cancer: A single institution cohort study
Presenter: Ka Man Cheung
Session: e-Poster Display Session
438P - Real-world data of relapse after adjuvant treatment (Tx) in high-risk melanoma
Presenter: Carolina Ortiz Velez
Session: e-Poster Display Session
439P - Immunohistochemical analysis of p53 and Ki-67 in glioblastoma (GBM) and their correlations with patient survival
Presenter: Paulo Luz
Session: e-Poster Display Session
440P - Blinded independent central review of oncology trials: The monitoring of readers' performance
Presenter: Hubert Beaumont
Session: e-Poster Display Session
Introduction
Presenter: Byoung Cho
Session: Boehringer Ingelheim - Treatment Considerations for Advanced NSCLC: Now and in the Future
Resources:
Webcast
Navigating first-line treatment decisions for EGFRM+ NSCLC: Extrapolating from Asian clinical trial experience
Presenter: John Wen-Cheng Chang
Session: Boehringer Ingelheim - Treatment Considerations for Advanced NSCLC: Now and in the Future
Resources:
Webcast
Tackling Uncommon EGFR mutations: Efficacy of EGFR TKIs in NSCLC
Presenter: Hiroshi Tanaka
Session: Boehringer Ingelheim - Treatment Considerations for Advanced NSCLC: Now and in the Future
Resources:
Webcast
KRAS-mutant NSCLC treatment advances on the horizon
Presenter: Byoung Cho
Session: Boehringer Ingelheim - Treatment Considerations for Advanced NSCLC: Now and in the Future
Resources:
Webcast
Closing
Presenter: Byoung Cho
Session: Boehringer Ingelheim - Treatment Considerations for Advanced NSCLC: Now and in the Future
Resources:
Webcast